Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis

Arthritis Res Ther. 2004;6(3):R220-31. doi: 10.1186/ar1167. Epub 2004 Mar 12.

Abstract

Collagen-induced arthritis (CIA) in mice is accompanied by splenomegaly due to the selective expansion of immature CD11b+ myeloblasts. Both disease manifestations are more pronounced in interferon-gamma receptor knock-out (IFN-gammaR KO) mice. We have taken advantage of this difference to test the hypothesis that the expanding CD11b+ splenic cell population constitutes a source from which osteoclast precursors are recruited to the joint synovia. We found larger numbers of osteoclasts and more severe bone destruction in joints of IFN-gammaR KO mice than in joints of wild-type mice. Osteoclast-like multinucleated cells appeared in splenocyte cultures established in the presence of macrophage colony-stimulating factor (M-CSF) and stimulated with the osteoclast-differentiating factor receptor activator of NF-kappaB ligand (RANKL) or with tumour necrosis factor-alpha (TNF-alpha). Significantly larger numbers of such cells could be generated from splenocytes of IFN-gammaR KO mice than from those of wild-type mice. This was not accompanied, as might have been expected, by increased concentrations of the intracellular adaptor protein TRAF6, known to be involved in signalling of RANKL- and TNF-alpha-induced osteoclast formation. Splenocyte cultures of IFN-gammaR KO mice also produced more TNF-alpha and more RANKL than those of wild-type mice. Finally, splenocytes isolated from immunised IFN-gammaR KO mice contained comparatively low levels of pro-interleukin-1beta (pro-IL-1beta) and pro-caspase-1, indicating more extensive conversion of pro-IL-1beta into secreted active IL-1beta. These observations provide evidence that all conditions are fulfilled for the expanding CD11b+ splenocytes to act as a source of osteoclasts and to be indirectly responsible for bone destruction in CIA. They also provide a plausible explanation for the higher susceptibility of IFN-gammaR KO mice to CIA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arthritis, Experimental / chemically induced*
  • Arthritis, Experimental / enzymology
  • Arthritis, Experimental / metabolism
  • Arthritis, Experimental / pathology
  • CD11b Antigen / metabolism*
  • Carrier Proteins / biosynthesis
  • Carrier Proteins / immunology
  • Caspases / metabolism
  • Cell Differentiation / physiology
  • Cells, Cultured
  • Collagen Type II / immunology
  • Enzyme Activation
  • Interferon gamma Receptor
  • Interferon-gamma / immunology
  • Interferon-gamma / metabolism
  • Interleukin-1 / metabolism
  • Joints / pathology
  • Macrophage Colony-Stimulating Factor
  • Membrane Glycoproteins / biosynthesis
  • Membrane Glycoproteins / immunology
  • Mice
  • Mice, Knockout
  • Mice, Mutant Strains
  • Myelopoiesis / physiology*
  • Osteoclasts / metabolism*
  • Osteoclasts / pathology
  • Protein Precursors / metabolism
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Receptors, Interferon / deficiency*
  • Spleen / chemistry
  • Spleen / cytology*
  • Spleen / metabolism
  • TNF Receptor-Associated Factor 6 / metabolism
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • CD11b Antigen
  • Carrier Proteins
  • Collagen Type II
  • Interleukin-1
  • Membrane Glycoproteins
  • Protein Precursors
  • RANK Ligand
  • Receptor Activator of Nuclear Factor-kappa B
  • Receptors, Interferon
  • TNF Receptor-Associated Factor 6
  • Tnfrsf11a protein, mouse
  • Tnfsf11 protein, mouse
  • Tumor Necrosis Factor-alpha
  • interleukin 1 precursor
  • Macrophage Colony-Stimulating Factor
  • Interferon-gamma
  • Caspases